Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases
Cardiovascular mortality makes up 66.3 % of the total mortality in Ukraine. Myocardial infarction, stroke, atherosclerosis of peripheral arteries are the diseases caused by atherosclerosis and are prevalent in the mortality structure. One of the most effective means of successful prevention of cardi...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dnipro State Medical University
2013-12-01
|
| Серія: | Medičnì Perspektivi |
| Предмети: | |
| Онлайн доступ: | http://medpers.dsma.dp.ua/issues/2013/N4/36-44.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|